What the business is, and whether it's a good one at a fair price.
Runs a network of standalone dialysis clinics delivering chronic outpatient kidney care, with the core business being the same procedure replicated across geographies. The company operates both own clinics and clinics under public-private partnership contracts with state governments such as Uttarakhand and Andhra Pradesh. Beyond India, it has entered the Philippines, Uzbekistan and is in the investment phase in Saudi Arabia, where a Ministry of Health dialysis tender is at the expression-of-interest stage. International markets command materially higher per-treatment prices than India, and the company is rolling up unorganised clinic operators in those geographies. On costs, materials (consumables such as dialyzers and blood lines) are the largest line at 22.7% of revenue, with employees at 17.2%; depreciation runs at 9.1% and capex at 11.9% of revenue, consistent with an asset-heavy clinic model.
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from NEPHROCARE HEALTH SERV L's filed financials and exchange disclosures
NEPHROCARE HEALTH SERV L is a Healthcare Services company listed on NSE and BSE, trading under the symbol NEPHROPLUS.
Not in the latest reported year — NEPHROCARE HEALTH SERV L's dividend payout for FY26 was nil.
Effectively yes. It holds ₹44 Cr more cash than debt. Debt stands at 0.07× equity.
On trailing P/E, NEPHROCARE HEALTH SERV L ranks 26 of 29 in Healthcare Service Provider — cheaper than 11% of them, against an industry median of 23.2×. This is a position, not a valuation judgement.
On a typical session NEPHROCARE HEALTH SERV L moves 1.51% — that is the median absolute close-to-close move across its last 181 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by NEPHROCARE HEALTH SERV L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.